TraceLink Inc., the world’s largest track and trace network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, announces new industry findings from its annual conference, NEXUS 17.
Interactive polling results indicated that the majority of pharmaceutical supply chain professionals (78% of attendees), believe that end-to-end visibility of pharmaceutical products in the supply chain is achievable within the next 5 years, with information sharing between trading partners cited as one of the most valuable business benefits.
At NEXUS 17 in Barcelona earlier this month, TraceLink introduced its strategy for leveraging the industry’s only digital supply chain network to facilitate a new era of real-time information sharing, addressing a critical information gap that has existed for decades between pharmaceutical companies, pharmacists and patients.
The first application unveiled within this road map, the Pharmacy Compliance and Digital Information Platform, enables any EU pharmacy to easily comply with verification and decommissioning requirements under the Falsified Medicines Directive (FMD), while simultaneously delivering a real-time dashboard for insights into pharmacy operations and enabling a direct communication channel from the pharmaceutical manufacturer to the pharmacy.
NEXUS 17 drew more than 200 pharmaceutical supply chain professionals and business leaders, representing more than 120 unique companies from 21 different countries.
The conference included educational content from 30 speakers, including esteemed keynote speaker, Dr Bertalan Mesko, “The Medical Futurist” and experts from Sanofi, Santen, Recipharm, Tjoapack, MIT and the European Medicines Verification Organisation (EMVO).
“There is tremendous value in connecting companies and trade partners together in an educational forum, allowing everyone to equally learn from collective wisdom.
This year, NEXUS truly showcased the power of the network in the pharmaceutical supply chain — demonstrated through inspirational keynotes, dynamic breakout and roundtable discussions, and high attendee engagement during the networking sessions,” said Shabbir Dahod, President and CEO, TraceLink.
“As serialisation deadlines fall into place, now is the time to leverage the foundation of an integrated network to enhance real-time communication and information exchange between all of the partners in the supply chain.”
“By enabling the flow of serialization data between more than 260,000 trade partners on our network, TraceLink is the only provider that can deliver the next step of capabilities by taking information and moving it end-to-end across the supply chain.”
NEXUS 17 attendees also responded to questions about serialization preparation, challenges and trade partner readiness, indicating the following:
- nearly one half (48%) of respondents preparing for serialisation indicated they are most worried about the exchange of information; testing and validation of systems (21%) is also a top concern among polling respondents
- the greatest serialisation challenge thus far, among NEXUS 17 attendees, has been line vendors’ inability to deliver a solution on time and within scope (47%); the second most cited challenge was lack of Level 3 functionality and flexibility to fulfil business requirements in the solution (26%)
- when asked about relationships with their contract manufacturing organisation (CMO) and contract packaging organisation (CPO) partners, 68% of pharmaceutical companies that responded, felt their CMOs and/or CPOs are not well prepared to meet serialisation requirements; 89% of respondents believe their CMOs should integrate serialisation into their current packaging lines with data management.
To access the full polling data results from NEXUS 17, download the Serialization Snapshot: The Current State of Readiness.
For those that missed NEXUS 17, photos and keynote slide presentations are available at www.nexus-tracelink.com.